Olaregen Therapeutix Inc.April 3, 2020

FDA 483 - Olaregen Therapeutix Inc. - April 03, 2020

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Olaregen Therapeutix Inc.

Record Details

Olaregen Therapeutix Inc., a medical device manufacturer in New Hyde Park, NY, was issued a Form FDA 483 following an inspection. The inspection revealed a significant compliance issue related to the firm's failure to maintain written Medical Device Reporting (MDR) procedures. Specifically, the firm lacked electronic MDR procedures for submitting reports on serious injuries and death incidents.

Company: Olaregen Therapeutix Inc.
Inspection Date: April 3, 2020
Product Type: Device
Office: Division of Human and Animal Food Operations - East I
Person: Kwong P. Lee (investigator)

Open in Dashboard

ID · 3e395610-984e-4505-953d-467bec0f1e2f